(Sharecast News) - London's top-flight index finished in positive territory on Friday, as investors weighed concerns about tightening Covid-19 restrictions with positive developments on the vaccine front.
The FTSE 100 ended the session up 1.49% at 5,919.58, while the FTSE 250 was 0.09% weaker at 17,822.91.
Sterling was stronger against its major trading pairs, last rising 0.2% on the dollar to $1.2935, and advancing 0.13% against the euro to €1.1036.
"Markets pushed upwards in the final session of the week, with markets regaining lost ground on the news that Pfizer could release a vaccine as soon as November," said IG senior market analyst Joshua Mahony.
"Meanwhile, the possibility that Pfizer could apply for a US emergency allowance to fast-track their vaccine has helped ease fears over the recent introduction of renewed restrictions throughout Europe.
"Of course, Pfizer's timeline that a vaccine could be approved in just a month remains dependent upon positive research outcomes between now and then."
However, Mahony said the company's willingness to map out an exact date did convey an "admirable degree of confidence" that the vaccine was good enough.
"From a UK perspective, ONS data shows that as many as 1 in 160 people in England could be currently infected with the virus, with the continued growth in cases bringing expectations of further restrictions."
The FTSE had fallen sharply on Thursday, as countries across Europe implemented further restrictions and London was moved to the so-called 'tier-2'.
On the Brexit front, meanwhile, reports during the afternoon suggested that talks between the UK and the EU were "over", according to officials at 10 Downing Street.
Prime Minister Boris Johnson earlier said the UK needed to prepare to trade with the 27-member bloc from 1 January without an agreement.
"The sticking points continue to be around fishing rights, level playing field provisions, as well as arbitration and governance benchmarks," said CMC Markets analyst Michael Hewson.
"With French President [Emmanuel] Macron also rattling a 'no deal' sabre it seems likely that we could well see some further twists and turns yet."
In equity markets, engine maker Rolls-Royce surged 13.74%, after Europe's aviation regulator said the Boeing 737 MAX is safe enough to return to the skies before the end of the year.
Luxury brand Burberry rallied 3.16% following well-received third-quarter results from LVMH Moet Hennessy Louis Vuitton.
Just Eat Takeaway was 3.76% higher after an upgrade to 'buy' at HSBC, while Premier Inn owner Whitbread was boosted 2.11% by an upgrade to 'buy' at Berenberg.
Dixons Carphone and JD Sports Fashion were both lifted by upgrades at RBC Capital Markets, by 3.07% and 2.86%, respectively.
Hedge fund Man Group gained 4.06% after it reported a 4% rise in third-quarter funds under management partly thanks to "robust" net inflows, although it also struck a note of caution about the outlook.
Outsourcer Serco rocketed 16.55% after upgrading its 2020 guidance thanks to strong revenue growth in the third quarter and good cost control.
IAG reversed earlier losses to eke out gains of 0.02%, after the Information Commissioner's Office fined British Airways £20m for a data breach affecting more than 400,000 customers.
On the downside, pub chain J D Wetherspoon plunged 19.43% after it swung to an annual loss as it felt the full impact of the coronavirus lockdown and said the government's latest set of curbs had led to a 15% fall in like-for-like sales in the first 11 weeks of the current fiscal year.
The company reported a pre-tax loss of £34m compared with £102m profit a year ago.
Revenue fell by a third to £1.26bn, and the final dividend was scrapped.
FTSE 100 (UKX) 5,919.58 1.49%
FTSE 250 (MCX) 17,822.91 -0.09%
techMARK (TASX) 3,824.22 1.02%
FTSE 100 - Risers
Rolls-Royce Holdings (RR.) 221.90p 13.74%
Smurfit Kappa Group (SKG) 3,214.00p 5.02%
Just Eat Takeaway.Com N.V. (CDI) (JET) 9,980.00p 3.98%
Experian (EXPN) 3,094.00p 3.84%
Relx plc (REL) 1,710.50p 3.57%
Schroders (SDR) 2,828.00p 3.47%
Melrose Industries (MRO) 130.10p 3.27%
Burberry Group (BRBY) 1,534.50p 3.16%
Smith (DS) (SMDS) 313.20p 3.06%
JD Sports Fashion (JD.) 799.60p 2.86%
FTSE 100 - Fallers
Land Securities Group (LAND) 525.20p -2.83%
Barratt Developments (BDEV) 536.80p -2.40%
BT Group (BT.A) 100.40p -1.76%
Taylor Wimpey (TW.) 116.65p -1.60%
British Land Company (BLND) 355.90p -1.52%
SEGRO (SGRO) 922.40p -0.84%
Persimmon (PSN) 2,510.00p -0.63%
Berkeley Group Holdings (The) (BKG) 4,326.00p -0.44%
Tesco (TSCO) 214.30p -0.28%
Rio Tinto (RIO) 4,646.50p -0.24%
FTSE 250 - Risers
Serco Group (SRP) 138.00p 16.55%
Babcock International Group (BAB) 257.50p 6.67%
Petrofac Ltd. (PFC) 112.55p 5.38%
Just Eat Takeaway.Com N.V. (CDI) (JET) 9,980.00p 3.98%
FirstGroup (FGP) 48.76p 3.97%
Oxford Biomedica (OXB) 812.00p 3.70%
Genus (GNS) 4,116.00p 3.53%
Wood Group (John) (WG.) 215.50p 3.46%
Meggitt (MGGT) 292.80p 3.43%
Oxford Instruments (OXIG) 1,678.00p 3.42%
FTSE 250 - Fallers
Wetherspoon (J.D.) (JDW) 780.00p -19.43%
Shaftesbury (SHB) 469.00p -5.94%
St. Modwen Properties (SMP) 317.00p -4.80%
Derwent London (DLN) 2,658.00p -4.33%
WH Smith (SMWH) 943.00p -4.07%
GCP Student Living (DIGS) 116.80p -3.64%
Trainline (TRN) 331.40p -3.38%
Jupiter Fund Management (JUP) 232.00p -3.27%
Fisher (James) & Sons (FSJ) 1,264.00p -3.07%
Capital & Counties Properties (CAPC) 111.20p -2.97%
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
(Sharecast News) - London stocks were well into positive territory at the close on Friday, with banks pacing the advance after well-received results from Barclays, as investors shrugged off news that the UK's economic recovery was stalling.
Gunsynd, an investment firm operating within the natural resources sector, announced that it has invested C$0.25 million (around £0.146 million) into precious metals royalty and streaming company Empress Royalty Corp. The group said the move complements existing investments in the precious metals sector, adding new commodity exposure to silver.
Clinical stage drug development firm, Evgen Pharma, has been given the green light to kick-start its STAR trial which will investigate whether its lead asset, SFX-01, can reduce the severity, or prevent the onset of, acute respiratory distress syndrome in patients with suspected COVID-19.
Braveheart Investment Group, the AIM-listed investment firm, said its investee company, Pharm2Farm ("P2F"), will launch the sale of a new antiviral face mask that has a ‘kill rate’ of over 90% for up to 7 hours for COVID-19 by the end of the year.
London-listed Sensyne Health, the UK-based clinical AI company, announced that it has signed a research collaboration agreement with US pharmaceutical company Bristol Myers Squibb ("BMS"), marking its fourth successive partnership with a major pharma company.